We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Biopharmaceutical company GenVec has announced it could receive up to $53 million under a new five-year contract with the National Institute of Allergy and Infectious Diseases (NIAID) to support the transfer of its manufacturing and purification processes to the NIH Vaccine Research Center (VRC).
The UK's National Institute for Health and Clinical Excellence (NICE) has announced that the appeals filed against a draft guidance on the use of drugs to treat Alzheimer's disease have not been upheld.
Dr. Reddy's Laboratories, an India-based pharma company, announced that it has settled patent litigation with British drugmaker GlaxoSmithKline (GSK) relating to its sumatriptan succinate tablets, the generic version of GSK's Imitrex.
Spanish drug maker Normon SA said on Sunday its hypertension tablets are not the cause of a mystery illness in Panama that has killed 19 people over the past month.
Johnson & Johnson (J&J) has filed an application with the New Zealand Commerce Commission to acquire the stock, assets and business of the Consumer Healthcare division of Pfizer Inc.
While Sanofi-Aventis
is busily gathering data on patient use of diet drug Acomplia in Europe to track side effects that may emerge during its initial months of sale, the company denied Oct. 6 that FDA has asked for more safety data as it weighs approving the diet pill for sale in the United States.
Pharmaceuticals maker and distributor Sigma Pharmaceuticals Ltd will most likely have to offer more than $2.20 per share if it is to secure rival Australian Pharmaceutical Industries Ltd (API), according to an analyst.
Eisai Co., Ltd., Japan's fourth largest drug company, received a boost yesterday after a US court ruled that a substance patent on its ulcer drug Aciphex was valid.